Skip to content

Establishing the Glycaemic Index of Vegetable Smoothies

Study to Establish Glycaemic Response to the Ingestion of Vegetable Smoothies Expressed as Glycaemic Index Following Best Practice Guidelines

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07729631
Acronym
VEG-GI
Enrollment
16
Registered
2026-07-27
Start date
2025-10-22
Completion date
2025-12-15
Last updated
2026-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycaemic Index, Glycaemic Response, Glycaemic Response Measurements

Keywords

Vegetable Smoothies, Glycaemic Index

Brief summary

Glycaemic responses to carbohydrates ingested as fruit and vegetables may vary depending on factors inherent to the fruit or vegetable, and on the type of sugar. The aim of this project is to investigate the glycaemic responses to two new fruit and vegetable smoothies, and to establish the glycaemic index for each product relative to a glucose reference. Participants will undertake 4 postprandial tests with 2 different test drinks following best practice guidelines for glycaemic index testing. The test drinks (GREEN and RED) will be matched for carbohydrate to the glucose reference (CONTROL) which will be sampled two times. Fingerstick capillary blood sampling will measure glucose concentrations. These data will provide insight into how differing formulations can alter the glycaemic responses to fruit and vegetable drinks.

Interventions

OTHERVegetable Smoothie

Commercially available fruit and vegetable smoothie

Sponsors

University of Bath
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Randomised, controlled crossover trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age: 18-65 years * Body mass index 18-30 kg/m2

Exclusion criteria

* diagnosis of any form of diabetes * intolerances or allergies to any of the study procedures (e.g. fructose/inulin intolerance) * Fructose malabsorption * Inborn errors of fructose metabolism (e.g. fructokinase deficiency, aldolase B deficiency, fructose-1,6-bisphosphatase deficiency) * pregnant or lactating * any condition that could introduce bias to the study (e.g. diagnoses of lipid disorders, including cardiovascular disease, or therapies that alter lipid or glucose metabolism, such as statins or niacin).

Design outcomes

Primary

MeasureTime frameDescription
Glycaemic indices for 2 test drinks measured using capillary blood samples120 minutesGlycaemic indices \[2-hour incremental area under the glucose curve (mmol/L-1x120 minutes) for each of the 2 test drinks relative to mean value of control conditions (CONTROL, REPLICATE CONTROL), expressed as a percentage\] in capillary blood samples

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 28, 2026